Alfresa Holdings Corporation (TYO:2784)
2,320.00
-46.00 (-1.94%)
At close: Dec 5, 2025
Alfresa Holdings Revenue
Alfresa Holdings had revenue of 771.64B JPY in the quarter ending September 30, 2025, with 5.13% growth. This brings the company's revenue in the last twelve months to 3.03T, up 5.11% year-over-year. In the fiscal year ending March 31, 2025, Alfresa Holdings had annual revenue of 2.96T with 3.59% growth.
Revenue (ttm)
3,034.46B
Revenue Growth
+5.11%
P/S Ratio
0.14
Revenue / Employee
243.69M
Employees
12,452
Market Cap
421.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2,961.05B | 102.55B | 3.59% |
| Mar 31, 2024 | 2,858.50B | 162.43B | 6.02% |
| Mar 31, 2023 | 2,696.07B | 110.43B | 4.27% |
| Mar 31, 2022 | 2,585.64B | -17.53B | -0.67% |
| Mar 31, 2021 | 2,603.17B | -95.34B | -3.53% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,213.71B |
| HOYA Corporation | 892.50B |
| Takeda Pharmaceutical Company | 4,417.00B |
| Daiichi Sankyo Company | 1,978.88B |
| Otsuka Holdings | 2,418.53B |
| Astellas Pharma | 2,006.82B |
| Terumo | 1,062.42B |
| Shionogi & | 437.26B |